Citadel Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $18.4M | Sell |
335,020
-1,260,038
| -79% | -$69.3M | ﹤0.01% | 1007 |
|
2025
Q1 | $113M | Buy |
1,595,058
+1,207,445
| +312% | +$85.4M | 0.02% | 226 |
|
2024
Q4 | $25.5M | Sell |
387,613
-816,784
| -68% | -$53.7M | ﹤0.01% | 819 |
|
2024
Q3 | $84.7M | Buy |
1,204,397
+646,545
| +116% | +$45.4M | 0.02% | 290 |
|
2024
Q2 | $45.9M | Sell |
557,852
-1,417,706
| -72% | -$117M | 0.01% | 514 |
|
2024
Q1 | $173M | Buy |
1,975,558
+1,620,613
| +457% | +$142M | 0.03% | 120 |
|
2023
Q4 | $34.2M | Buy |
354,945
+213,413
| +151% | +$20.6M | 0.01% | 617 |
|
2023
Q3 | $12.5M | Sell |
141,532
-340,807
| -71% | -$30.2M | ﹤0.01% | 1023 |
|
2023
Q2 | $41.8M | Buy |
482,339
+358,771
| +290% | +$31.1M | 0.01% | 485 |
|
2023
Q1 | $12M | Sell |
123,568
-6,933
| -5% | -$674K | ﹤0.01% | 1184 |
|
2022
Q4 | $13.5M | Sell |
130,501
-871,813
| -87% | -$90.2M | ﹤0.01% | 1101 |
|
2022
Q3 | $85M | Sell |
1,002,314
-150,761
| -13% | -$12.8M | 0.02% | 218 |
|
2022
Q2 | $95.6M | Sell |
1,153,075
-937,328
| -45% | -$77.7M | 0.02% | 173 |
|
2022
Q1 | $161M | Buy |
2,090,403
+732,488
| +54% | +$56.5M | 0.03% | 100 |
|
2021
Q4 | $120M | Buy |
1,357,915
+1,308,848
| +2,667% | +$116M | 0.02% | 159 |
|
2021
Q3 | $3.79M | Sell |
49,067
-911,095
| -95% | -$70.4M | ﹤0.01% | 2312 |
|
2021
Q2 | $80.1M | Sell |
960,162
-673,518
| -41% | -$56.2M | 0.02% | 311 |
|
2021
Q1 | $123M | Sell |
1,633,680
-1,361,590
| -45% | -$103M | 0.03% | 166 |
|
2020
Q4 | $263M | Buy |
2,995,270
+517,914
| +21% | +$45.4M | 0.07% | 47 |
|
2020
Q3 | $188M | Buy |
2,477,356
+2,222,384
| +872% | +$169M | 0.05% | 63 |
|
2020
Q2 | $31.4M | Sell |
254,972
-4,355
| -2% | -$537K | 0.01% | 566 |
|
2020
Q1 | $21.9M | Sell |
259,327
-1,780,826
| -87% | -$150M | 0.01% | 639 |
|
2019
Q4 | $172M | Buy |
2,040,153
+282,923
| +16% | +$23.9M | 0.07% | 87 |
|
2019
Q3 | $118M | Buy |
1,757,230
+587,616
| +50% | +$39.6M | 0.06% | 162 |
|
2019
Q2 | $100M | Buy |
1,169,614
+40,966
| +4% | +$3.51M | 0.05% | 204 |
|
2019
Q1 | $100M | Sell |
1,128,648
-229,037
| -17% | -$20.3M | 0.05% | 179 |
|
2018
Q4 | $116M | Sell |
1,357,685
-1,101,023
| -45% | -$93.8M | 0.06% | 122 |
|
2018
Q3 | $238M | Buy |
2,458,708
+625,303
| +34% | +$60.6M | 0.11% | 67 |
|
2018
Q2 | $173M | Buy |
1,833,405
+457,896
| +33% | +$43.1M | 0.09% | 98 |
|
2018
Q1 | $112M | Sell |
1,375,509
-939,566
| -41% | -$76.2M | 0.06% | 145 |
|
2017
Q4 | $206M | Buy |
2,315,075
+671,639
| +41% | +$59.9M | 0.13% | 79 |
|
2017
Q3 | $153M | Buy |
1,643,436
+1,401,415
| +579% | +$130M | 0.12% | 79 |
|
2017
Q2 | $22M | Sell |
242,021
-224,884
| -48% | -$20.4M | 0.02% | 573 |
|
2017
Q1 | $41M | Sell |
466,905
-233,832
| -33% | -$20.5M | 0.04% | 342 |
|
2016
Q4 | $58M | Sell |
700,737
-272,548
| -28% | -$22.6M | 0.06% | 171 |
|
2016
Q3 | $90M | Sell |
973,285
-680,698
| -41% | -$63M | 0.09% | 111 |
|
2016
Q2 | $129M | Sell |
1,653,983
-540,892
| -25% | -$42.1M | 0.14% | 63 |
|
2016
Q1 | $181M | Buy |
2,194,875
+2,121,458
| +2,890% | +$175M | 0.23% | 26 |
|
2015
Q4 | $7.69M | Sell |
73,417
-353,165
| -83% | -$37M | 0.01% | 937 |
|
2015
Q3 | $44.9M | Sell |
426,582
-153,235
| -26% | -$16.1M | 0.04% | 371 |
|
2015
Q2 | $79.3M | Sell |
579,817
-385,389
| -40% | -$52.7M | 0.07% | 242 |
|
2015
Q1 | $120M | Sell |
965,206
-492,997
| -34% | -$61.4M | 0.11% | 144 |
|
2014
Q4 | $132M | Buy |
1,458,203
+256,311
| +21% | +$23.2M | 0.13% | 97 |
|
2014
Q3 | $86.7M | Buy |
1,201,892
+634,138
| +112% | +$45.8M | 0.09% | 168 |
|
2014
Q2 | $35.3M | Sell |
567,754
-69,792
| -11% | -$4.34M | 0.04% | 385 |
|
2014
Q1 | $43.5M | Buy |
637,546
+89,804
| +16% | +$6.13M | 0.05% | 344 |
|
2013
Q4 | $38.5M | Buy |
547,742
+80,715
| +17% | +$5.67M | 0.05% | 344 |
|
2013
Q3 | $33.7M | Sell |
467,027
-419,963
| -47% | -$30.3M | 0.05% | 361 |
|
2013
Q2 | $49.5M | Buy |
+886,990
| New | +$49.5M | 0.09% | 226 |
|